Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

Astellas Pharma Korea, Inc.23 enrolled

Overview

The purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide to support their clinical decision making. There are no secondary objectives for this study.

Data collection for this study will be conducted through 2 rounds of web-based surveys of health care professionals (HCPs). A meeting with the panelists will be held as a 3rd round if a consensus for pre determined key questions is not achieved after the 2 rounds of the survey.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metastatic Hormone-Sensitive Prostate Cancer

Interventions

No InterventionOTHER

No investigational drug will be administered to participants in this study.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Urologist from university hospitals in South Korea. * Has a minimum 10 years of practice experience (experience as a military or public health doctor could be considered practice experience) * Sees a minimum of 50 mHSPC patients in a year. * At least 10 publications in SCIE (Science Citation Index Expanded) journals in the past 5 years. Exclusion Criteria: * Urologist in private practice.

Locations (1)

KR82001

Seoul, South Korea

Outcomes

Primary Outcomes

Treatment plans for patients with mHSPC

Treatment plans for patients with mHSPC within the local healthcare environment will be collected via online surveys and a consensus meeting will be held if required.

Time frame: Up to 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.